Industries > Pharma > African Horse Sickness Treatment Market Report to 2031
African Horse Sickness Treatment Market Report to 2031
Forecasts by Clinical Forms (Pulmonary Form or “Dunkop”, Cardiac Form or “Dikkop”, Mixed Form, and Horse Sickness Fever), By Diagnosis Tests (Laboratory Tests for Viral Antigens, Enzyme-linked Immunosorbent Assays (ELISA), Reverse-transcription PCR assays, Serological Tests, Prevention Treatment, and Vaccines) PLUS COVID-19 Recovery Scenarios
African Horse Sickness Treatment Market– our new study reveals trends, R&D progress, and predicted revenues
Where is the African Horse Sickness Treatment market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2031, assessing data, trends, opportunities and business prospects there.
Discover how to stay ahead
Our 500+ page report provides 600+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing African Horse Sickness Treatment Market. See how to exploit the opportunities.
Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and submarkets
African Horse Sickness Treatment Market: By Clinical Forms
• Pulmonary Form or “Dunkop”
• Cardiac Form or “Dikkop”
• Mixed Form
• Horse Sickness Fever
African Horse Sickness Treatment Market: By Diagnosis Tests
• Laboratory Tests for Viral Antigens
• Enzyme-linked Immunosorbent Assays (ELISA)
• Reverse-transcription PCR assays
• Serological Tests
• Prevention Treatment
• Vaccines
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:
• North America
o U.S.
o Canada
• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Australia
o South Korea
o Rest of Asia Pacific
• Latin America
o Brazil
o Mexico
o Argentina
o Rest of Latin America
• Middle East and Africa
o Turkey
o Saudi Arabia
o South Africa
o UAE
o Egypt
o Rest of Middle East and Africa
The report also includes profiles and for some of the leading companies in the African Horse Sickness Treatment Market, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
Overall world revenue for African Horse Sickness Treatment Market will surpass $xx million in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the African Horse Sickness Treatment Market report helps you
In summary, our 500+ page report provides you with the following knowledge:
• Revenue forecasts to 2031 for African Horse Sickness Treatment Market, with forecasts for Clinical Forms and Diagnosis Tests, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for 5 regional and 16 key national markets – See forecasts for the African Horse Sickness Treatment market in North America, Europe, Asia-Pacific and Rest of the World. Also forecasted is the market in the US, Canada, Argentina, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 10 of the major companies involved in the African Horse Sickness Treatment Market. Some of the company’s profiled in this report include Veterinary Serum and Vaccine Research Institute and Onderstepoort Biological Products SOC Ltd.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today African Horse Sickness Treatment Market Report to 2031: Forecasts by Clinical Forms (Pulmonary Form or “Dunkop”, Cardiac Form or “Dikkop”, Mixed Form, and Horse Sickness Fever), By Diagnosis Tests (Laboratory Tests for Viral Antigens, Enzyme-linked Immunosorbent Assays (ELISA), Reverse-transcription PCR assays, Serological Tests, Prevention Treatment, and Vaccines) PLUS COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the African Horse Sickness Treatment Market
2.1. African Horse Sickness Treatment Market Definition
2.2. Clinical Forms Submarkets Definitions
2.3. Diagnosis Tests Submarkets Definitions
3. African Horse Sickness Treatment Market Overview
3.1. Global African Horse Sickness Treatment Market Size and Forecast by Region
3.2. Global African Horse Sickness Treatment Market Share by Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. The existence of the standard operating procedures and the guidelines for the African horse sickness disease
3.3.2. Market Restraints/Challenges
3.3.2.1. The modified-live, multivalent vaccine is given to the horses do not guarantee that the horses are completely protected from the African horse sickness
3.3.3. Opportunities
3.3.3.1. Emerging Markets Offer Lucrative Growth Opportunities
3.3.3.2. Development of Preventive Vaccines
3.3.4. Global African Horse Sickness Treatment Market: Trends
3.3.5. SWOT Analysis
3.3.5.1. Strengths
3.3.5.2. Weaknesses
3.3.5.3. Opportunities
3.3.5.4. Threats
3.3.6. Porter’s Five Forces Analysis
3.3.6.1. Competitive Rivalry
3.3.6.2. Supplier Power
3.3.6.3. Buyer Power
3.3.6.4. Threat of Substitution
3.3.6.5. The threat of New Entry
4. Global African Horse Sickness Treatment Market Analysis and Forecast, 2021-2031 by Clinical Forms (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Pulmonary Form or “Dunkop”
4.1.2. Cardiac Form or “Dikkop”
4.1.3. Mixed Form
4.1.4. Horse Sickness Fever
5. Global African Horse Sickness Treatment Market Analysis and Forecast, 2021-2031 by Diagnosis Tests (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Laboratory Tests for Viral Antigens
5.1.2. Enzyme-linked Immunosorbent Assays (ELISA)
5.1.3. Reverse-transcription PCR assays
5.1.4. Serological Tests
5.1.5. Prevention Treatment
5.1.6. Vaccines
6. North America African Horse Sickness Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
6.1. Market Overview
6.2. North America African Horse Sickness Treatment Market Size and Forecast by Clinical Forms Type
6.3. North America African Horse Sickness Treatment Market Size and Forecast by Diagnosis Tests
6.4. U.S. African Horse Sickness Treatment Market
6.5. Canada African Horse Sickness Treatment Market
7. Europe African Horse Sickness Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
7.1. Market Overview
7.2. Europe African Horse Sickness Treatment Market Size and Forecast by Clinical Forms Type
7.3. Europe African Horse Sickness Treatment Market Size and Forecast by Diagnosis Tests
7.4. UK African Horse Sickness Treatment Market
7.5. Germany African Horse Sickness Treatment Market
7.6. France African Horse Sickness Treatment Market
7.7. Rest of Europe African Horse Sickness Treatment Market
8. Asia Pacific African Horse Sickness Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
8.1. Market Overview
8.2. Asia Pacific African Horse Sickness Treatment Market Size and Forecast by Clinical Forms Type
8.3. Asia Pacific African Horse Sickness Treatment Market Size and Forecast by Diagnosis Tests
8.4. China African Horse Sickness Treatment Market
8.5. India African Horse Sickness Treatment Market
8.6. Japan African Horse Sickness Treatment Market
8.7. Rest of Asia Pacific African Horse Sickness Treatment Market
9. Latin America African Horse Sickness Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. Latin America African Horse Sickness Treatment Market Size and Forecast by Clinical Forms Type
9.3. Latin America African Horse Sickness Treatment Market Size and Forecast by Diagnosis Tests
9.3.1. Brazil African Horse Sickness Treatment Market
9.3.2. Mexico African Horse Sickness Treatment Market
9.3.3. Rest of Latin America African Horse Sickness Treatment Market
10. MEA African Horse Sickness Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. MEA African Horse Sickness Treatment Market Size and Forecast by Clinical Forms Type
10.3. MEA African Horse Sickness Treatment Market Size and Forecast by Diagnosis Tests
10.4. GCC African Horse Sickness Treatment Market
10.5. South Africa African Horse Sickness Treatment Market
10.6. Rest of MEA African Horse Sickness Treatment Market
11. Companies in the African Horse Sickness Treatment Market
11.1. Veterinary Serum
11.1.1. Company Snapshot
11.1.2. Company Overview
11.1.3. Financial Performance (2015-2019)
11.1.3.1. Net Revenue
11.1.3.2. Gross Profit
11.1.3.3. Geographical Revenue, 2019
11.1.4. Clinical Forms Offerings
11.1.5. Recent Initiatives (2017-2019)
11.2. Vaccine Research Institute
11.2.1. Company Snapshot
11.2.2. Company Overview
11.2.3. Financial Performance (2015-2019)
11.2.3.1. Net Revenue
11.2.3.2. Gross Profit
11.2.3.3. Geographical Revenue, 2019
11.2.4. Clinical Forms Offerings
11.2.5. Recent Initiatives (2017-2019)
11.3. Onderstepoort Biological Products SOC Ltd.
11.3.1. Company Snapshot
11.3.2. Company Overview
11.3.3. Financial Performance (2015-2019)
11.3.3.1. Net Revenue
11.3.3.2. Gross Profit
11.3.3.3. Geographical Revenue, 2019
11.4. Other Notable Players
12. Conclusion
13. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1 African Horse Sickness Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2 African Horse Sickness Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3 African Horse Sickness Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4 African Horse Sickness Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5 African Horse Sickness Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6 African Horse Sickness Treatment Market Drivers & Restraints 2020
Table 7 African Horse Sickness Treatment Submarket Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8 African Horse Sickness Treatment Submarket Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9 African Horse Sickness Treatment Submarket Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10 African Horse Sickness Treatment Submarket Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11 African Horse Sickness Treatment Submarket Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12 Pulmonary Form or “Dunkop” Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) before COVID)
Table 13 Pulmonary Form or “Dunkop” Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14 Pulmonary Form or “Dunkop” Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15 Pulmonary Form or “Dunkop” Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16 Pulmonary Form or “Dunkop” Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17 Cardiac Form or “Dikkop” Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18 Cardiac Form or “Dikkop” Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19 Cardiac Form or “Dikkop” Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20 Cardiac Form or “Dikkop” Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21 Cardiac Form or “Dikkop” Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22 Mixed Form Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) before COVID)
Table 23 Mixed Form Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24 Mixed Form Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25 Mixed Form Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26 Mixed Form Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27 Horse Sickness Fever Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 28 Horse Sickness Fever Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29 Horse Sickness Fever Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30 Horse Sickness Fever Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31 Horse Sickness Fever Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32 African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 33 African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 34 African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 35 African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 36 African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 37 Laboratory Tests for Viral Antigens Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 38 Laboratory Tests for Viral Antigens Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39 Laboratory Tests for Viral Antigens Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 40 Laboratory Tests for Viral Antigens Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 41 Laboratory Tests for Viral Antigens Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 42 Enzyme-linked Immunosorbent Assays (ELISA) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 43 Enzyme-linked Immunosorbent Assays (ELISA) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 44 Enzyme-linked Immunosorbent Assays (ELISA) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 45 Enzyme-linked Immunosorbent Assays (ELISA) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 46 Enzyme-linked Immunosorbent Assays (ELISA) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 47 Reverse-transcription PCR assays Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 48 Reverse-transcription PCR assays Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 49 Reverse-transcription PCR assays Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 50 Reverse-transcription PCR assays Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 51 Reverse-transcription PCR assays Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 52 Serological Tests Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 53 Serological Tests Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 54 Serological Tests Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 55 Serological Tests Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 56 Serological Tests Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 57 Prevention Treatment Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 58 Prevention Treatment Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 59 Prevention Treatment Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 60 Prevention Treatment Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 61 Prevention Treatment Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 62 Vaccines Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 63 Vaccines Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 64 Vaccines Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 65 Vaccines Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 66 Vaccines Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 67 Regional African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 68 Regional African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 69 Regional African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 70 Regional African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 71 Regional African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 72 North America African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 73 North America African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 74 North America African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 75 North America African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 76 North America African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 77 North America African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 78 North America African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 79 North America African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 80 North America African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 81 North America African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 82 North America African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 83 North America African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 84 North America African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 85 North America African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 86 North America African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 87 US African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 88 US African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 89 US African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 90 US African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 91 US African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 92 Canada African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 93 Canada African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 94 Canada African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 95 Canada African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 96 Canada African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 97 Europe African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 98 Europe African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 99 Europe African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 100 Europe African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 101 Europe African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 102 Europe African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 103 Europe African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 104 Europe African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 105 Europe African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 106 Europe African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 107 Europe African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 108 Europe African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 109 Europe African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 110 Europe African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 111 Europe African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 112 UK African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 113 UK African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 114 UK African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 115 UK African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 116 UK African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 117 Germany African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 118 Germany African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 119 Germany African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 120 Germany African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 121 Germany African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 122 France African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 123 France African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 124 France African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 125 France African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 126 France African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 127 Rest of Europe African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 128 Rest of Europe African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 129 Rest of Europe African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 130 Rest of Europe African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 131 Rest of Europe African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 132 Asia Pacific African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 133 Asia Pacific African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 134 Asia Pacific African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 135 Asia Pacific African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 136 Asia Pacific African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 137 Asia Pacific African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 138 Asia Pacific African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 139 Asia Pacific African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 140 Asia Pacific African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 141 Asia Pacific African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 142 Asia Pacific African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 143 Asia Pacific African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 144 Asia Pacific African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 145 Asia Pacific African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 146 Asia Pacific African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 147 China African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 148 China African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 149 China African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 150 China African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 151 China African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 152 India African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 153 India African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 154 India African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 155 India African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 156 India African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 157 Japan African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 158 Japan African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 159 Japan African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 160 Japan African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 161 Japan African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 162 RoAPAC African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 163 RoAPAC African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 164 RoAPAC African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 165 RoAPAC African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 166 RoAPAC African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 167 Middle East African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 168 Middle East African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 169 Middle East African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 170 Middle East African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 171 Middle East African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 172 Middle East African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 173 Middle East African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 174 Middle East African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 175 Middle East African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 176 Middle East African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 177 Latin America African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 178 Latin America African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 179 Latin America African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 180 Latin America African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 181 Latin America African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 182 Latin America African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 183 Latin America African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 184 Latin America African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 185 Latin America African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 186 Latin America African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 187 Africa African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 188 Africa African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 189 Africa African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 190 Africa African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 191 Africa African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 192 Africa African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 193 Africa African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 194 Africa African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 195 Africa African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 196 Africa African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 197 Leading 10 African Horse Sickness Treatment Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 198 Veterinary Serum Profile 2019 (CEO, HQ, Founded, Website)
Table 199 Veterinary Serum African Horse Sickness Treatment Selected Recent Contracts 2019 (Date, Contract Type, Details)
Table 200 Veterinary Serum African Horse Sickness Treatment Clinical Forms Offering (Segment, Clinical Forms Offerings)
Table 201 Vaccine Research Institute Profile 2019 (CEO, HQ, Founded, Website)
Table 202 Vaccine Research Institute African Horse Sickness Treatment Selected Recent Contracts 2019 (Date, Contract Type, Details)
Table 203 Vaccine Research Institute African Horse Sickness Treatment Clinical Forms Offering (Segment, Clinical Forms Offerings)
Table 204 Onderstepoort Biological Products SOC Ltd. Profile 2019 (CEO, HQ, Founded, Website)
Table 205 Onderstepoort Biological Products SOC Ltd. African Horse Sickness Treatment Selected Recent Contracts 2017-2019 (Date, Contract Type, Details)
Table 206 Onderstepoort Biological Products SOC Ltd. African Horse Sickness Treatment Clinical Forms Offering (Segment, Clinical Forms Offerings)
Table 207 Other Companies Involved in the African Horse Sickness Treatment Market 2020 (Company, Location)
LIST OF FIGURES
Figure 1 African Horse Sickness Treatment Market Overview, By Clinical Forms
Figure 2 African Horse Sickness Treatment Market Overview, By Diagnosis Tests
Figure 3 African Horse Sickness Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 4 African Horse Sickness Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 5 African Horse Sickness Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 6 African Horse Sickness Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 7 African Horse Sickness Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 8 African Horse Sickness Treatment Market Drivers & Restraints 2020
Figure 9 African Horse Sickness Treatment Submarket Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 10 African Horse Sickness Treatment Submarket Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 11 African Horse Sickness Treatment Submarket Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 12 African Horse Sickness Treatment Submarket Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 13 African Horse Sickness Treatment Submarket Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 14 Pulmonary Form or “Dunkop” Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) before COVID)
Figure 15 Pulmonary Form or “Dunkop” Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 16 Pulmonary Form or “Dunkop” Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 17 Pulmonary Form or “Dunkop” Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 18 Pulmonary Form or “Dunkop” Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 19 Cardiac Form or “Dikkop” Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 20 Cardiac Form or “Dikkop” Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 21 Cardiac Form or “Dikkop” Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 22 Cardiac Form or “Dikkop” Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 23 Cardiac Form or “Dikkop” Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 24 Mixed Form Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) before COVID)
Figure 25 Mixed Form Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 26 Mixed Form Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 27 Mixed Form Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 28 Mixed Form Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 29 Horse Sickness Fever Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 30 Horse Sickness Fever Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 31 Horse Sickness Fever Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 32 Horse Sickness Fever Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 33 Horse Sickness Fever Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 34 African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 35 African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 36 African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 37 African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 38 African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 39 Laboratory Tests for Viral Antigens Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 40 Laboratory Tests for Viral Antigens Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 41 Laboratory Tests for Viral Antigens Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 42 Laboratory Tests for Viral Antigens Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 43 Laboratory Tests for Viral Antigens Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 44 Enzyme-linked Immunosorbent Assays (ELISA) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 45 Enzyme-linked Immunosorbent Assays (ELISA) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 46 Enzyme-linked Immunosorbent Assays (ELISA) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 47 Enzyme-linked Immunosorbent Assays (ELISA) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 48 Enzyme-linked Immunosorbent Assays (ELISA) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 49 Reverse-transcription PCR assays Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 50 Reverse-transcription PCR assays Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 51 Reverse-transcription PCR assays Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 52 Reverse-transcription PCR assays Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 53 Reverse-transcription PCR assays Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 54 Serological Tests Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 55 Serological Tests Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 56 Serological Tests Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 57 Serological Tests Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 58 Serological Tests Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 59 Prevention Treatment Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 60 Prevention Treatment Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 61 Prevention Treatment Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 62 Prevention Treatment Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 63 Prevention Treatment Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 64 Vaccines Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 65 Vaccines Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 66 Vaccines Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 67 Vaccines Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 68 Vaccines Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 69 Regional African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 70 Regional African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 71 Regional African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 72 Regional African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 73 Regional African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 74 North America African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 75 North America African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 76 North America African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 77 North America African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 78 North America African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 79 North America African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 80 North America African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 81 North America African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 82 North America African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 83 North America African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 84 North America African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 85 North America African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 86 North America African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 87 North America African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 88 North America African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 89 US African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 90 US African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 91 US African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 92 US African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 93 US African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 94 Canada African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 95 Canada African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 96 Canada African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 97 Canada African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 98 Canada African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 99 Europe African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 100 Europe African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 101 Europe African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 102 Europe African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 103 Europe African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 104 Europe African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 105 Europe African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 106 Europe African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 107 Europe African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 108 Europe African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 109 Europe African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 110 Europe African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 111 Europe African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 112 Europe African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 113 Europe African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 114 UK African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 115 UK African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 116 UK African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 117 UK African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 118 UK African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 119 Germany African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 120 Germany African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 121 Germany African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 122 Germany African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 123 Germany African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 124 France African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 125 France African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 126 France African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 127 France African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 128 France African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 129 Rest of Europe African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 130 Rest of Europe African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 131 Rest of Europe African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 132 Rest of Europe African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 133 Rest of Europe African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 134 Asia Pacific African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 135 Asia Pacific African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 136 Asia Pacific African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 137 Asia Pacific African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 138 Asia Pacific African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 139 Asia Pacific African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 140 Asia Pacific African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 141 Asia Pacific African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 142 Asia Pacific African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 143 Asia Pacific African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 144 Asia Pacific African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 145 Asia Pacific African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 146 Asia Pacific African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 147 Asia Pacific African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 148 Asia Pacific African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 149 China African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 150 China African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 151 China African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 152 China African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 153 China African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 154 India African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 155 India African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 156 India African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 157 India African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 158 India African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 159 Japan African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 160 Japan African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 161 Japan African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 162 Japan African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 163 Japan African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 164 RoAPAC African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 165 RoAPAC African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 166 RoAPAC African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 167 RoAPAC African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 168 RoAPAC African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 169 Middle East African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 170 Middle East African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 171 Middle East African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 172 Middle East African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 173 Middle East African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 174 Middle East African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 175 Middle East African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 176 Middle East African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 177 Middle East African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 178 Middle East African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 179 Latin America African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 180 Latin America African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 181 Latin America African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 182 Latin America African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 183 Latin America African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 184 Latin America African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 185 Latin America African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 186 Latin America African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 187 Latin America African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 188 Latin America African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 189 Africa African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 190 Africa African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 191 Africa African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 192 Africa African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 193 Africa African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 194 Africa African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 195 Africa African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 196 Africa African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 197 Africa African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 198 Africa African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the African Horse Sickness Treatment Market
2.1. African Horse Sickness Treatment Market Definition
2.2. Clinical Forms Submarkets Definitions
2.3. Diagnosis Tests Submarkets Definitions
3. African Horse Sickness Treatment Market Overview
3.1. Global African Horse Sickness Treatment Market Size and Forecast by Region
3.2. Global African Horse Sickness Treatment Market Share by Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. The existence of the standard operating procedures and the guidelines for the African horse sickness disease
3.3.2. Market Restraints/Challenges
3.3.2.1. The modified-live, multivalent vaccine is given to the horses do not guarantee that the horses are completely protected from the African horse sickness
3.3.3. Opportunities
3.3.3.1. Emerging Markets Offer Lucrative Growth Opportunities
3.3.3.2. Development of Preventive Vaccines
3.3.4. Global African Horse Sickness Treatment Market: Trends
3.3.5. SWOT Analysis
3.3.5.1. Strengths
3.3.5.2. Weaknesses
3.3.5.3. Opportunities
3.3.5.4. Threats
3.3.6. Porter’s Five Forces Analysis
3.3.6.1. Competitive Rivalry
3.3.6.2. Supplier Power
3.3.6.3. Buyer Power
3.3.6.4. Threat of Substitution
3.3.6.5. The threat of New Entry
4. Global African Horse Sickness Treatment Market Analysis and Forecast, 2021-2031 by Clinical Forms (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Pulmonary Form or “Dunkop”
4.1.2. Cardiac Form or “Dikkop”
4.1.3. Mixed Form
4.1.4. Horse Sickness Fever
5. Global African Horse Sickness Treatment Market Analysis and Forecast, 2021-2031 by Diagnosis Tests (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Laboratory Tests for Viral Antigens
5.1.2. Enzyme-linked Immunosorbent Assays (ELISA)
5.1.3. Reverse-transcription PCR assays
5.1.4. Serological Tests
5.1.5. Prevention Treatment
5.1.6. Vaccines
6. North America African Horse Sickness Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
6.1. Market Overview
6.2. North America African Horse Sickness Treatment Market Size and Forecast by Clinical Forms Type
6.3. North America African Horse Sickness Treatment Market Size and Forecast by Diagnosis Tests
6.4. U.S. African Horse Sickness Treatment Market
6.5. Canada African Horse Sickness Treatment Market
7. Europe African Horse Sickness Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
7.1. Market Overview
7.2. Europe African Horse Sickness Treatment Market Size and Forecast by Clinical Forms Type
7.3. Europe African Horse Sickness Treatment Market Size and Forecast by Diagnosis Tests
7.4. UK African Horse Sickness Treatment Market
7.5. Germany African Horse Sickness Treatment Market
7.6. France African Horse Sickness Treatment Market
7.7. Rest of Europe African Horse Sickness Treatment Market
8. Asia Pacific African Horse Sickness Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
8.1. Market Overview
8.2. Asia Pacific African Horse Sickness Treatment Market Size and Forecast by Clinical Forms Type
8.3. Asia Pacific African Horse Sickness Treatment Market Size and Forecast by Diagnosis Tests
8.4. China African Horse Sickness Treatment Market
8.5. India African Horse Sickness Treatment Market
8.6. Japan African Horse Sickness Treatment Market
8.7. Rest of Asia Pacific African Horse Sickness Treatment Market
9. Latin America African Horse Sickness Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. Latin America African Horse Sickness Treatment Market Size and Forecast by Clinical Forms Type
9.3. Latin America African Horse Sickness Treatment Market Size and Forecast by Diagnosis Tests
9.3.1. Brazil African Horse Sickness Treatment Market
9.3.2. Mexico African Horse Sickness Treatment Market
9.3.3. Rest of Latin America African Horse Sickness Treatment Market
10. MEA African Horse Sickness Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. MEA African Horse Sickness Treatment Market Size and Forecast by Clinical Forms Type
10.3. MEA African Horse Sickness Treatment Market Size and Forecast by Diagnosis Tests
10.4. GCC African Horse Sickness Treatment Market
10.5. South Africa African Horse Sickness Treatment Market
10.6. Rest of MEA African Horse Sickness Treatment Market
11. Companies in the African Horse Sickness Treatment Market
11.1. Veterinary Serum
11.1.1. Company Snapshot
11.1.2. Company Overview
11.1.3. Financial Performance (2015-2019)
11.1.3.1. Net Revenue
11.1.3.2. Gross Profit
11.1.3.3. Geographical Revenue, 2019
11.1.4. Clinical Forms Offerings
11.1.5. Recent Initiatives (2017-2019)
11.2. Vaccine Research Institute
11.2.1. Company Snapshot
11.2.2. Company Overview
11.2.3. Financial Performance (2015-2019)
11.2.3.1. Net Revenue
11.2.3.2. Gross Profit
11.2.3.3. Geographical Revenue, 2019
11.2.4. Clinical Forms Offerings
11.2.5. Recent Initiatives (2017-2019)
11.3. Onderstepoort Biological Products SOC Ltd.
11.3.1. Company Snapshot
11.3.2. Company Overview
11.3.3. Financial Performance (2015-2019)
11.3.3.1. Net Revenue
11.3.3.2. Gross Profit
11.3.3.3. Geographical Revenue, 2019
11.4. Other Notable Players
12. Conclusion
13. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1 African Horse Sickness Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2 African Horse Sickness Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3 African Horse Sickness Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4 African Horse Sickness Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5 African Horse Sickness Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6 African Horse Sickness Treatment Market Drivers & Restraints 2020
Table 7 African Horse Sickness Treatment Submarket Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8 African Horse Sickness Treatment Submarket Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9 African Horse Sickness Treatment Submarket Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10 African Horse Sickness Treatment Submarket Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11 African Horse Sickness Treatment Submarket Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12 Pulmonary Form or “Dunkop” Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) before COVID)
Table 13 Pulmonary Form or “Dunkop” Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14 Pulmonary Form or “Dunkop” Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15 Pulmonary Form or “Dunkop” Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16 Pulmonary Form or “Dunkop” Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17 Cardiac Form or “Dikkop” Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18 Cardiac Form or “Dikkop” Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19 Cardiac Form or “Dikkop” Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20 Cardiac Form or “Dikkop” Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21 Cardiac Form or “Dikkop” Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22 Mixed Form Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) before COVID)
Table 23 Mixed Form Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24 Mixed Form Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25 Mixed Form Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26 Mixed Form Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27 Horse Sickness Fever Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 28 Horse Sickness Fever Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29 Horse Sickness Fever Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30 Horse Sickness Fever Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31 Horse Sickness Fever Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32 African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 33 African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 34 African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 35 African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 36 African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 37 Laboratory Tests for Viral Antigens Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 38 Laboratory Tests for Viral Antigens Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39 Laboratory Tests for Viral Antigens Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 40 Laboratory Tests for Viral Antigens Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 41 Laboratory Tests for Viral Antigens Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 42 Enzyme-linked Immunosorbent Assays (ELISA) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 43 Enzyme-linked Immunosorbent Assays (ELISA) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 44 Enzyme-linked Immunosorbent Assays (ELISA) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 45 Enzyme-linked Immunosorbent Assays (ELISA) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 46 Enzyme-linked Immunosorbent Assays (ELISA) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 47 Reverse-transcription PCR assays Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 48 Reverse-transcription PCR assays Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 49 Reverse-transcription PCR assays Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 50 Reverse-transcription PCR assays Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 51 Reverse-transcription PCR assays Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 52 Serological Tests Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 53 Serological Tests Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 54 Serological Tests Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 55 Serological Tests Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 56 Serological Tests Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 57 Prevention Treatment Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 58 Prevention Treatment Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 59 Prevention Treatment Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 60 Prevention Treatment Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 61 Prevention Treatment Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 62 Vaccines Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 63 Vaccines Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 64 Vaccines Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 65 Vaccines Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 66 Vaccines Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 67 Regional African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 68 Regional African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 69 Regional African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 70 Regional African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 71 Regional African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 72 North America African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 73 North America African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 74 North America African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 75 North America African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 76 North America African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 77 North America African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 78 North America African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 79 North America African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 80 North America African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 81 North America African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 82 North America African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 83 North America African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 84 North America African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 85 North America African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 86 North America African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 87 US African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 88 US African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 89 US African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 90 US African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 91 US African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 92 Canada African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 93 Canada African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 94 Canada African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 95 Canada African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 96 Canada African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 97 Europe African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 98 Europe African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 99 Europe African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 100 Europe African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 101 Europe African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 102 Europe African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 103 Europe African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 104 Europe African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 105 Europe African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 106 Europe African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 107 Europe African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 108 Europe African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 109 Europe African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 110 Europe African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 111 Europe African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 112 UK African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 113 UK African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 114 UK African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 115 UK African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 116 UK African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 117 Germany African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 118 Germany African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 119 Germany African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 120 Germany African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 121 Germany African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 122 France African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 123 France African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 124 France African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 125 France African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 126 France African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 127 Rest of Europe African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 128 Rest of Europe African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 129 Rest of Europe African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 130 Rest of Europe African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 131 Rest of Europe African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 132 Asia Pacific African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 133 Asia Pacific African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 134 Asia Pacific African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 135 Asia Pacific African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 136 Asia Pacific African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 137 Asia Pacific African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 138 Asia Pacific African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 139 Asia Pacific African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 140 Asia Pacific African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 141 Asia Pacific African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 142 Asia Pacific African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 143 Asia Pacific African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 144 Asia Pacific African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 145 Asia Pacific African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 146 Asia Pacific African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 147 China African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 148 China African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 149 China African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 150 China African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 151 China African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 152 India African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 153 India African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 154 India African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 155 India African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 156 India African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 157 Japan African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 158 Japan African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 159 Japan African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 160 Japan African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 161 Japan African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 162 RoAPAC African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 163 RoAPAC African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 164 RoAPAC African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 165 RoAPAC African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 166 RoAPAC African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 167 Middle East African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 168 Middle East African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 169 Middle East African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 170 Middle East African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 171 Middle East African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 172 Middle East African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 173 Middle East African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 174 Middle East African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 175 Middle East African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 176 Middle East African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 177 Latin America African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 178 Latin America African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 179 Latin America African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 180 Latin America African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 181 Latin America African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 182 Latin America African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 183 Latin America African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 184 Latin America African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 185 Latin America African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 186 Latin America African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 187 Africa African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 188 Africa African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 189 Africa African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 190 Africa African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 191 Africa African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 192 Africa African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 193 Africa African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 194 Africa African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 195 Africa African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 196 Africa African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 197 Leading 10 African Horse Sickness Treatment Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 198 Veterinary Serum Profile 2019 (CEO, HQ, Founded, Website)
Table 199 Veterinary Serum African Horse Sickness Treatment Selected Recent Contracts 2019 (Date, Contract Type, Details)
Table 200 Veterinary Serum African Horse Sickness Treatment Clinical Forms Offering (Segment, Clinical Forms Offerings)
Table 201 Vaccine Research Institute Profile 2019 (CEO, HQ, Founded, Website)
Table 202 Vaccine Research Institute African Horse Sickness Treatment Selected Recent Contracts 2019 (Date, Contract Type, Details)
Table 203 Vaccine Research Institute African Horse Sickness Treatment Clinical Forms Offering (Segment, Clinical Forms Offerings)
Table 204 Onderstepoort Biological Products SOC Ltd. Profile 2019 (CEO, HQ, Founded, Website)
Table 205 Onderstepoort Biological Products SOC Ltd. African Horse Sickness Treatment Selected Recent Contracts 2017-2019 (Date, Contract Type, Details)
Table 206 Onderstepoort Biological Products SOC Ltd. African Horse Sickness Treatment Clinical Forms Offering (Segment, Clinical Forms Offerings)
Table 207 Other Companies Involved in the African Horse Sickness Treatment Market 2020 (Company, Location)
LIST OF FIGURES
Figure 1 African Horse Sickness Treatment Market Overview, By Clinical Forms
Figure 2 African Horse Sickness Treatment Market Overview, By Diagnosis Tests
Figure 3 African Horse Sickness Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 4 African Horse Sickness Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 5 African Horse Sickness Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 6 African Horse Sickness Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 7 African Horse Sickness Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 8 African Horse Sickness Treatment Market Drivers & Restraints 2020
Figure 9 African Horse Sickness Treatment Submarket Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 10 African Horse Sickness Treatment Submarket Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 11 African Horse Sickness Treatment Submarket Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 12 African Horse Sickness Treatment Submarket Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 13 African Horse Sickness Treatment Submarket Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 14 Pulmonary Form or “Dunkop” Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) before COVID)
Figure 15 Pulmonary Form or “Dunkop” Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 16 Pulmonary Form or “Dunkop” Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 17 Pulmonary Form or “Dunkop” Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 18 Pulmonary Form or “Dunkop” Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 19 Cardiac Form or “Dikkop” Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 20 Cardiac Form or “Dikkop” Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 21 Cardiac Form or “Dikkop” Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 22 Cardiac Form or “Dikkop” Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 23 Cardiac Form or “Dikkop” Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 24 Mixed Form Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) before COVID)
Figure 25 Mixed Form Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 26 Mixed Form Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 27 Mixed Form Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 28 Mixed Form Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 29 Horse Sickness Fever Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 30 Horse Sickness Fever Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 31 Horse Sickness Fever Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 32 Horse Sickness Fever Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 33 Horse Sickness Fever Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 34 African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 35 African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 36 African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 37 African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 38 African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 39 Laboratory Tests for Viral Antigens Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 40 Laboratory Tests for Viral Antigens Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 41 Laboratory Tests for Viral Antigens Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 42 Laboratory Tests for Viral Antigens Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 43 Laboratory Tests for Viral Antigens Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 44 Enzyme-linked Immunosorbent Assays (ELISA) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 45 Enzyme-linked Immunosorbent Assays (ELISA) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 46 Enzyme-linked Immunosorbent Assays (ELISA) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 47 Enzyme-linked Immunosorbent Assays (ELISA) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 48 Enzyme-linked Immunosorbent Assays (ELISA) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 49 Reverse-transcription PCR assays Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 50 Reverse-transcription PCR assays Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 51 Reverse-transcription PCR assays Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 52 Reverse-transcription PCR assays Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 53 Reverse-transcription PCR assays Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 54 Serological Tests Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 55 Serological Tests Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 56 Serological Tests Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 57 Serological Tests Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 58 Serological Tests Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 59 Prevention Treatment Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 60 Prevention Treatment Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 61 Prevention Treatment Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 62 Prevention Treatment Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 63 Prevention Treatment Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 64 Vaccines Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 65 Vaccines Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 66 Vaccines Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 67 Vaccines Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 68 Vaccines Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 69 Regional African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 70 Regional African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 71 Regional African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 72 Regional African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 73 Regional African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 74 North America African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 75 North America African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 76 North America African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 77 North America African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 78 North America African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 79 North America African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 80 North America African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 81 North America African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 82 North America African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 83 North America African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 84 North America African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 85 North America African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 86 North America African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 87 North America African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 88 North America African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 89 US African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 90 US African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 91 US African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 92 US African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 93 US African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 94 Canada African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 95 Canada African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 96 Canada African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 97 Canada African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 98 Canada African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 99 Europe African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 100 Europe African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 101 Europe African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 102 Europe African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 103 Europe African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 104 Europe African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 105 Europe African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 106 Europe African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 107 Europe African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 108 Europe African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 109 Europe African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 110 Europe African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 111 Europe African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 112 Europe African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 113 Europe African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 114 UK African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 115 UK African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 116 UK African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 117 UK African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 118 UK African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 119 Germany African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 120 Germany African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 121 Germany African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 122 Germany African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 123 Germany African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 124 France African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 125 France African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 126 France African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 127 France African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 128 France African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 129 Rest of Europe African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 130 Rest of Europe African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 131 Rest of Europe African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 132 Rest of Europe African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 133 Rest of Europe African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 134 Asia Pacific African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 135 Asia Pacific African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 136 Asia Pacific African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 137 Asia Pacific African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 138 Asia Pacific African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 139 Asia Pacific African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 140 Asia Pacific African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 141 Asia Pacific African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 142 Asia Pacific African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 143 Asia Pacific African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 144 Asia Pacific African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 145 Asia Pacific African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 146 Asia Pacific African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 147 Asia Pacific African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 148 Asia Pacific African Horse Sickness Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 149 China African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 150 China African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 151 China African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 152 China African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 153 China African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 154 India African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 155 India African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 156 India African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 157 India African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 158 India African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 159 Japan African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 160 Japan African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 161 Japan African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 162 Japan African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 163 Japan African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 164 RoAPAC African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 165 RoAPAC African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 166 RoAPAC African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 167 RoAPAC African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 168 RoAPAC African Horse Sickness Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 169 Middle East African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 170 Middle East African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 171 Middle East African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 172 Middle East African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 173 Middle East African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 174 Middle East African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 175 Middle East African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 176 Middle East African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 177 Middle East African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 178 Middle East African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 179 Latin America African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 180 Latin America African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 181 Latin America African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 182 Latin America African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 183 Latin America African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 184 Latin America African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 185 Latin America African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 186 Latin America African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 187 Latin America African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 188 Latin America African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 189 Africa African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 190 Africa African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 191 Africa African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 192 Africa African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 193 Africa African Horse Sickness Treatment Market Forecast by Clinical Forms 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 194 Africa African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 195 Africa African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 196 Africa African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 197 Africa African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 198 Africa African Horse Sickness Treatment Market Forecast by Diagnosis Tests 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Companies Profiled in the Report
1. Veterinary Serum
2. Vaccine Research Institute
3. Onderstepoort Biological Products SOC Ltd
List of Companies Mentioned in the Report:
1. Shionogi & Co.
2. Shanghai Fosun Pharmaceutical
3. Stada Arzneimittel
4. Lundbeck
5. Zhejiang International
6. Lupin
7. Taisho Pharmaceutical
8. Tasly Pharmaceutical
9. Ipsen
10. Sino Biopharmaceutical
11. Ono Pharmaceutical
12. Aurobindo
13. Cipla
14. Johnson & Johnson
15. Roche
16. Novartis
17. Sanofi
18. Bayer
19. Merck & Co. (MSD)
20. Eli Lilly
21. Astrazeneca
22. Teva
23. CR Pharmaceutical
24. Bristol-Myers Squibb
25. Merck (KGaA)
26. Novo Nordisk
27. Takeda
28. Allergan
29. Astellas Pharma
30. Mylan
31. Otsuka
32. Daiichi Sankyo
33. Valeant Pharmaceuticals
34. UCB
35. Zoetis
36. Eisai
37. Chugai Pharmaceutical
38. Perrigo
39. Sun Pharmaceutical
40. Mitsubishi Tanabe Pharma
41. Sichuan Languang Development
42. Sumitomo Dainippon Pharma
43. Yunnan Baiyao
44. Aspen Pharmacare
45. Endo
46. Kangmei Pharmaceutical
47. Galenica
48. Guangzhou Baiyunshan Pharmaceutical
49. Kyowa Hakko Kirin
50. Mallinckrod
List of Organizations Mentioned in the Report:
1. European Commission
2. European Medicines Agency
3. Food and Drug Administration
4. Medicines and Healthcare Regulatory Agency
5. Ministry of Industry and Information technology
6. National Institute of Health
7. World Health Organisation (WHO)
8. Centers for Disease Control and Prevention
9. National Academy of Medicine
10. Agency for Healthcare Research and Quality
11. National Accreditation Board for Hospitals & Healthcare Providers
12. National Institute for Health Research
13. Chinese Food and Drug Administration
14. Care Quality Commission
15. British Medical Association
16. United States Department of Health and Human Services
17. Healthcare Information and Management Systems Society
18. Patient safety organization
19. NHS Digital
20. Australian Commission On Safety And Quality In Health Care
1. Veterinary Serum
2. Vaccine Research Institute
3. Onderstepoort Biological Products SOC Ltd
List of Companies Mentioned in the Report:
1. Shionogi & Co.
2. Shanghai Fosun Pharmaceutical
3. Stada Arzneimittel
4. Lundbeck
5. Zhejiang International
6. Lupin
7. Taisho Pharmaceutical
8. Tasly Pharmaceutical
9. Ipsen
10. Sino Biopharmaceutical
11. Ono Pharmaceutical
12. Aurobindo
13. Cipla
14. Johnson & Johnson
15. Roche
16. Novartis
17. Sanofi
18. Bayer
19. Merck & Co. (MSD)
20. Eli Lilly
21. Astrazeneca
22. Teva
23. CR Pharmaceutical
24. Bristol-Myers Squibb
25. Merck (KGaA)
26. Novo Nordisk
27. Takeda
28. Allergan
29. Astellas Pharma
30. Mylan
31. Otsuka
32. Daiichi Sankyo
33. Valeant Pharmaceuticals
34. UCB
35. Zoetis
36. Eisai
37. Chugai Pharmaceutical
38. Perrigo
39. Sun Pharmaceutical
40. Mitsubishi Tanabe Pharma
41. Sichuan Languang Development
42. Sumitomo Dainippon Pharma
43. Yunnan Baiyao
44. Aspen Pharmacare
45. Endo
46. Kangmei Pharmaceutical
47. Galenica
48. Guangzhou Baiyunshan Pharmaceutical
49. Kyowa Hakko Kirin
50. Mallinckrod
List of Organizations Mentioned in the Report:
1. European Commission
2. European Medicines Agency
3. Food and Drug Administration
4. Medicines and Healthcare Regulatory Agency
5. Ministry of Industry and Information technology
6. National Institute of Health
7. World Health Organisation (WHO)
8. Centers for Disease Control and Prevention
9. National Academy of Medicine
10. Agency for Healthcare Research and Quality
11. National Accreditation Board for Hospitals & Healthcare Providers
12. National Institute for Health Research
13. Chinese Food and Drug Administration
14. Care Quality Commission
15. British Medical Association
16. United States Department of Health and Human Services
17. Healthcare Information and Management Systems Society
18. Patient safety organization
19. NHS Digital
20. Australian Commission On Safety And Quality In Health Care
Download sample pages
Complete the form below to download your free sample pages for African Horse Sickness Treatment Market Report to 2031Download sample pages
Complete the form below to download your free sample pages for African Horse Sickness Treatment Market Report to 2031Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: jamie.roberts@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Jamie Roberts stating your chosen report title to jamie.roberts@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email jamie.roberts@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Drug Delivery Technologies Market Report 2024-2034
The global Drug Delivery Technologies market is estimated at US$1,729.6 billion in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period 2024-2034.
23 April 2024
Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034
The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.
18 April 2024
Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034
The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.
17 April 2024
Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034
The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.
12 April 2024
